The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Dr Elizabeth Robertson, Diabetes UK’s director of research, said: “Dr Reith’s idea, and her determination to bring the ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

The first-of-its-kind study will be the first to evaluate closed-loop technology in people using Insulin Pens with ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

in patients with type 1 diabetes (T1D) who require multiple daily insulin injections. The Luna system was developed as a ...

What you need to know More than 500 million people live with diabetes, and around 783 million are expected to have the ...

The global insulin pens market is witnessing unprecedented growth, propelled by the escalating prevalence of diabetes worldwide. According to recent industry reports, the market, valued at USD 35 ...

Millions more with Type 2 diabetes also take insulin as their ... than a dozen insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our work for ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...